Literature DB >> 20226241

Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation: association between idiopathic pneumonia syndrome and acute graft-versus-host disease.

Qifa Liu1, Juan Ning, Yu Zhang, Xiuli Wu, Xiaodan Luo, Zhiping Fan.   

Abstract

OBJECTIVE: To explore the association between idiopathic pneumonia syndrome (IPS) and acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation.
METHODS: Established acute GVHD model of C57BL/6-->BALB/c mice. Chest computed tomography (CT) scans were dynamically performed in recipient mice after transplant. Lung histopathology and cytokine levels (including TNF-alpha and IFN-gamma) were examined in three experimental groups: mice receiving simple irradiation, syngeneic transplants, and allogeneic transplants.
RESULTS: All allogeneic transplant mice developed aGVHD. On CT, most aGVHD mice had bilateral diffuse lung infiltrates, while syngeneic transplant mice had normal lungs. On histopathology, aGVHD mice had acute pneumonitis. On immunohistochemistry, the infiltrates were mainly CD4+ T cells during aGVHD onset, but CD8+ T cells predominated during aGVHD progression. Lung TNF-alpha and IFN-gamma levels were higher in the three experimental groups than in normal controls on days +3 and +7 post-transplant. On day +7, TNF-alpha levels were higher in allogeneic than in syngeneic transplant mice; IFN-gamma levels were not different. On days +12 and +16, TNF-alpha levels were higher but IFN-gamma levels were lower in allogeneic mice than in syngeneic transplant mice.
CONCLUSIONS: The underlying cause of IPS is aGVHD. T cells and TNF-alpha may play a role in the pathogenesis of aGVHD-induced IPS. IPS progression may be associated with decreasing lung IFN-gamma levels. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226241     DOI: 10.1016/j.trim.2010.02.004

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  3 in total

1.  Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells.

Authors:  Rui-Qing Zhou; Xiaobo Wang; Yong-Bin Ye; Bo Lu; Jing Wang; Zi-Wen Guo; Wen-Jian Mo; Zheng Yang; Pathomthat Srisuk; Le-Ping Yan; Xiao-Jun Xu
Journal:  Exp Ther Med       Date:  2022-05-16       Impact factor: 2.751

2.  Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.

Authors:  Tereza Martinu; Christine V Kinnier; Jesse Sun; Francine L Kelly; Margaret E Nelson; Stavros Garantziotis; W Michael Foster; Scott M Palmer
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

3.  Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis.

Authors:  Min Cao; Huihui Liu; Yujun Dong; Wei Liu; Zhengyu Yu; Qingya Wang; Qingyun Wang; Zeying Liang; Yuan Li; Hanyun Ren
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.